Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 2 |
NXP Semiconductors
NXPI
|
+$351M |
| 3 |
Oracle
ORCL
|
+$279M |
| 4 |
Palo Alto Networks
PANW
|
+$268M |
| 5 |
Boston Scientific
BSX
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$517M |
| 2 |
ExxonMobil
XOM
|
+$385M |
| 3 |
Cenovus Energy
CVE
|
+$292M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$236M |
| 5 |
Phillips 66
PSX
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.01% |
| 2 | Technology | 7.76% |
| 3 | Financials | 7.66% |
| 4 | Healthcare | 7.12% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
CALL
Ascendis Pharma A/S
ASND
$16.3B
| $3.25M | ﹤0.01% |
35,000
-15,000
| -30% | -$1.41M |
|
3177
Casey's General Stores
CASY
$28B
| $3.25M | ﹤0.01% |
17,567
+3,133
| +22% | +$630K |
|
|
DFTX
3178
Definium Therapeutics
DFTX
$5.51B
| $3.25M | ﹤0.01% |
338,341
+309,252
| +1,063% | +$3.91M |
|
3179
RELX
RELX
$63.6B
| $3.23M | ﹤0.01% |
119,960
-424,139
| -78% | -$12.2M |
|
|
LBPH
3180
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $3.22M | ﹤0.01% |
1,043,216
-2,713
| -0.3% | -$12.5K |
|
|
SPCMU
3181
DELISTED
Sound Point Acquisition Corp I, Ltd Unit
SPCMU
| $3.22M | ﹤0.01% |
320,000
-300,000
| -48% | -$3.03M |
|
3182
Arcturus Therapeutics
ARCT
$432M
| $3.22M | ﹤0.01% |
+204,596
| New | +$4.01M |
|
3183
PUT
Best Buy
BBY
$17.4B
| $3.22M | ﹤0.01% |
49,400
-472,600
| -91% | -$39.4M |
|
3184
Cytokinetics
CYTK
$10B
| $3.21M | ﹤0.01% |
81,742
+68,637
| +524% | +$2.76M |
|
3185
PROG Holdings
PRG
$1.56B
| $3.21M | ﹤0.01% |
194,581
-574,874
| -75% | -$14.7M |
|
3186
C4 Therapeutics
CCCC
$474M
| $3.21M | ﹤0.01% |
425,647
-565,294
| -57% | -$4.97M |
|
3187
PUT
Privia Health
PRVA
$2.66B
| $3.2M | ﹤0.01% |
+110,000
| New | +$2.8M |
|
|
NESRW
3188
CALL
DELISTED
National Energy Services Reunited Corp. Warrant
NESRW
| $3.2M | ﹤0.01% |
9,700,200
+1,200
| +0% | +$615 |
|
3189
PUT
DuPont de Nemours
DD
$18.5B
| $3.2M | ﹤0.01% |
45,888
+14,021
| +44% | +$1.15M |
|
3190
CALL
Gold Fields
GFI
$40.9B
| $3.19M | ﹤0.01% |
+350,000
| New | +$4.18M |
|
|
LAZR
3191
DELISTED
Luminar Technologies
LAZR
| $3.19M | ﹤0.01% |
35,879
-52,494
| -59% | -$8.39M |
|
3192
Oportun Financial
OPRT
$338M
| $3.18M | ﹤0.01% |
384,076
+192,209
| +100% | +$2.22M |
|
|
ASAQ
3193
DELISTED
Atlantic Avenue Acquisition Corp
ASAQ
| $3.17M | ﹤0.01% |
319,790
-719
| -0.2% | -$7.11K |
|
3194
PUT
AbCellera Biologics
ABCL
$3.68B
| $3.17M | ﹤0.01% |
+297,200
| New | +$2.52M |
|
3195
Bilibili
BILI
$6.95B
| $3.16M | ﹤0.01% |
123,597
-553,167
| -82% | -$13.3M |
|
3196
First Bancorp
FBP
$4.28B
| $3.16M | ﹤0.01% |
245,108
-928,904
| -79% | -$12.7M |
|
|
NESR
3197
National Energy Services Reunited Corp
NESR
$3.47B
| $3.16M | ﹤0.01% |
466,566
+75,131
| +19% | +$547K |
|
3198
CALL
Idexx Laboratories
IDXX
$43.7B
| $3.16M | ﹤0.01% |
+9,000
| New | +$3.67M |
|
3199
CALL
Nucor
NUE
$56.8B
| $3.15M | ﹤0.01% |
30,200
-48,800
| -62% | -$6.6M |
|
3200
Newmark Group
NMRK
$2.87B
| $3.15M | ﹤0.01% |
325,796
+309,018
| +1,842% | +$3.58M |
|
Similar funds
Israel Englander's Q2 2022 Portfolio in Review
As of Q2 2022, Israel Englander held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Israel Englander deployed $8.78B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 60% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.
- Israel Englander's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
- Israel Englander added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
- Israel Englander's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
- Israel Englander fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
- Israel Englander's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
- Israel Englander opened 1,144 new positions and closed 1,065 in Q2 2022.
- Israel Englander's portfolio value fell 15% quarter-over-quarter to $161B.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.